Cardiovascular Disease

Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself.

What is Cardiovascular Disease?

Diseases of disorders of this system are termed cardiovascular diseases. Cardiovascular diseases kill an estimated 17 million people worldwide each year. Majority of these are due to heart attacks and strokes.

Cardiovascular Benefits of Blueberries

Cardiovascular Disease Research

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Lowering Risk for Cardiovascular Disease

Cardiovascular Disease Diagnosis

What is Microvascular Endothelial Dysfunction?

Non-Communicable Diseases

Cardiovascular Drugs

Latest Cardiovascular Disease News and Research

PMOS rethink reframes a common hormone disorder as a whole-body disease

A new review reframes PCOS, now proposed as PMOS, as a systemic endocrine and metabolic disorder shaped by genetic, epigenetic, ovarian, metabolic, and neuroendocrine pathways. It highlights why inconsistent diagnosis and symptom-focused care have limited progress, while targeted therapies, biomarkers, machine learning, and organ-on-chip models may support more personalized treatment.

18 Jun 2026

New biological age tools could reveal health risks before symptoms appear

A JCI review traces biological age measurement from functional tests and blood biomarkers to epigenetic, proteomic, imaging, wearable, and AI-based clocks. It finds that these tools can improve risk prediction beyond chronological age, but standardization, interpretability, and prospective validation are needed before routine clinical use.

18 Jun 2026

AI-designed drug for Parkinson's begins first human trial

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia Therapeutics with the completion of first-in-human dosing in the Phase I study of ISM8969.

17 Jun 2026

Resistance training reduces major heart disease risk for active women

Women who lift weights may have a lower risk of major heart disease, especially when combined with aerobic exercise, according to a new study published today in JACC, the flagship journal of the American College of Cardiology.

17 Jun 2026

Smartphone apps and wearables help heart disease patients stay active

Smartphone apps, fitness trackers and wearable devices help people with heart disease get more physical activity in their daily lives, according to an analysis of previous research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

17 Jun 2026

New biological ratio effectively predicts cardiovascular risk

Announcing a new article publication in BIO Integration. Insulin resistance (IR) and chronic kidney disease (CKD) are independent risk factors for cardiovascular disease (CVD).

16 Jun 2026

NHS dental costs will hit £5.3 billion as older adults carry the burden

A UK cost-of-illness projection estimates that direct NHS dental treatment costs for adult caries and periodontal disease will rise by 20%, from £4.42 billion in 2020 to £5.30 billion by 2050. The burden shifts strongly toward older adults and severe disease, supporting prevention and earlier intervention as NHS dental planning priorities.

15 Jun 2026

Global study links rising obesity to premature heart disease deaths

Researchers are warning that obesity is reshaping the global cardiovascular disease crisis, as trend data covering 204 countries reveal that heart disease now peaks in people aged 50-54 rather than the elderly and increasingly in South Asia, where rates have grown more than three times faster than global averages, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2026

Study reveals different factors driving rising neurological disease rates

The growing number of people living with Parkinson's disease (PD), multiple sclerosis (MS) and motor neuron disease (MND) is being driven by different underlying factors, according to new research due to be presented at the European Academy of Neurology (EAN) Congress 2026 and published in Neurology.

15 Jun 2026

Reinforcing daily rhythms helps the brain recover after stroke

A new study from scientists at the University of Rochester Medicine suggests that reinforcing the body's natural daily rhythms to improve sleep could help the brain recover after a stroke, pointing to a potential new strategy to improve brain waste clearance and outcomes long after the initial injury.

15 Jun 2026

Synthetic cooling agents in e-cigarettes link to abnormal heartbeats

Synthetic cooling ingredients added to e-cigarettes caused abnormal heartbeats (arrhythmias) and increased cardiovascular risk measures in mice and lab-grown human heart cells, according to new independent research published today in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal of the American Heart Association.

15 Jun 2026

American Heart Association launches platform for earlier heart failure risk identification

Nearly 7 million people in the United States are living with heart failure, and that number is expected to grow in the years ahead.

15 Jun 2026

AI model could improve screening for primary aldosteronism

A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases patients' risk of cardiovascular complications, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

Urine drug test may boost adherence to blood pressure medications

The largest ever UK trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment.

12 Jun 2026

Comprehensive food regulations lower obesity risk among children

Chile's complementary set of policies targeting food products high in fat, salt and sugar plausibly reduces the risk of school age children being overweight or having obesity, finds a study published in The Lancet.

11 Jun 2026

FemTech innovations are transforming women's health care worldwide

JMIR Publications released a News and Perspectives story on technological innovations in women's health care.

11 Jun 2026

Trial finds prunes do not outperform calcium and vitamin D for male bone density

A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density in older men susceptible to, or with, osteopenia. Although some bone turnover biomarkers differed between prune and control groups, these changes did not translate into measurable bone density benefits beyond calcium and vitamin D3 supplementation.

11 Jun 2026

Oral GLP-1 drug elecoglipron helps adults lose up to 11.8% body weight

Once-daily oral elecoglipron produced dose-dependent weight loss in adults with obesity or overweight without diabetes, with mean reductions reaching 10.5% at 26 weeks and 11.8% at 36 weeks in the highest-dose weekly-titration group. The phase 2 trial found no evidence of a weight-loss plateau by 36 weeks, while gastrointestinal adverse events were common but generally manageable.

11 Jun 2026

BU professor to examine the role of postpartum hypertension on recurrent HDP risk

Samantha Parker Kelleher, along with researchers at BU School of Public Health and Boston Medical Center, will examine the role of high blood pressure during the postpartum period on the risk of developing recurrent hypertensive disorders of pregnancy, such as preeclampsia and gestational hypertension.

11 Jun 2026

Intravenous statins during heart attack reduce cardiac muscle damage

Reducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, even when the blocked coronary artery is reopened in a timely manner.

11 Jun 2026